Albert NL - Search Results

1

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.

Blobner J, Dengler L, Blobner S, Eberle C, Weller J, Teske N, Karschnia P, Rühlmann K, Heinrich K, Ziemann F, Greif PA, Jeremias I, Wuerstlein R, Hasselmann K, Dorostkar M, Harter PN, Quach S, Stoecklein V, Albert NL, Niyazi M, Tonn JC, Thon N, Christoph Westphalen B, von Baumgarten L. Blobner J, et al. Among authors: albert nl. Neurooncol Adv. 2023 May 12;5(1):vdad060. doi: 10.1093/noajnl/vdad060. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37287694 Free PMC article.

2

Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.

Seystahl K, Stoecklein V, Schüller U, Rushing E, Nicolas G, Schäfer N, Ilhan H, Pangalu A, Weller M, Tonn JC, Sommerauer M, Albert NL. Seystahl K, et al. Among authors: albert nl. Neuro Oncol. 2016 Nov;18(11):1538-1547. doi: 10.1093/neuonc/now060. Epub 2016 Apr 21. Neuro Oncol. 2016. PMID: 27106404 Free PMC article.

3

¹⁸F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis.

Unterrainer M, Galldiks N, Suchorska B, Kowalew LC, Wenter V, Schmid-Tannwald C, Niyazi M, Bartenstein P, Langen KJ, Albert NL. Unterrainer M, et al. Among authors: albert nl. J Nucl Med. 2017 Apr;58(4):584-589. doi: 10.2967/jnumed.116.180075. Epub 2016 Oct 6. J Nucl Med. 2017. PMID: 27754904 Free article.

4

K27M midline gliomas display malignant progression by imaging and histology.

Vettermann FJ, Neumann JE, Suchorska B, Bartenstein P, Giese A, Dorostkar MM, Albert NL, Schüller U. Vettermann FJ, et al. Among authors: albert nl. Neuropathol Appl Neurobiol. 2017 Aug;43(5):458-462. doi: 10.1111/nan.12371. Neuropathol Appl Neurobiol. 2017. PMID: 27997032 No abstract available.

5

¹⁸F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?

Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M. Fleischmann DF, et al. Among authors: albert nl. J Neurooncol. 2017 Apr;132(2):277-286. doi: 10.1007/s11060-016-2366-8. Epub 2017 Jan 19. J Neurooncol. 2017. PMID: 28102485

6

TSPO PET for glioma imaging using the novel ligand ¹⁸F-GE-180: first results in patients with glioblastoma.

Albert NL, Unterrainer M, Fleischmann DF, Lindner S, Vettermann F, Brunegraf A, Vomacka L, Brendel M, Wenter V, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M. Albert NL, et al. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2230-2238. doi: 10.1007/s00259-017-3799-9. Epub 2017 Aug 19. Eur J Nucl Med Mol Imaging. 2017. PMID: 28821920

7

Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.

Suchorska B, Giese A, Biczok A, Unterrainer M, Weller M, Drexler M, Bartenstein P, Schüller U, Tonn JC, Albert NL. Suchorska B, et al. Among authors: albert nl. Neuro Oncol. 2018 Jan 22;20(2):279-288. doi: 10.1093/neuonc/nox153. Neuro Oncol. 2018. PMID: 29016996 Free PMC article.

8

The endothelial prostate-specific membrane antigen is highly expressed in gliosarcoma and visualized by [68Ga]-PSMA-11 PET: a theranostic outlook for brain tumor patients?

Unterrainer M, Niyazi M, Ruf V, Bartenstein P, Albert NL. Unterrainer M, et al. Among authors: albert nl. Neuro Oncol. 2017 Nov 29;19(12):1698-1699. doi: 10.1093/neuonc/nox172. Neuro Oncol. 2017. PMID: 29045711 Free PMC article. No abstract available.

9

Biological tumour volumes of gliomas in early and standard 20-40 min ¹⁸F-FET PET images differ according to IDH mutation status.

Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Unterrainer M, et al. Among authors: albert nl. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1242-1249. doi: 10.1007/s00259-018-3969-4. Epub 2018 Feb 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29487977

10

Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min ¹⁸F-FET PET images differ according to IDH mutation status.

Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Unterrainer M, et al. Among authors: albert nl. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1078. doi: 10.1007/s00259-018-3991-6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29541813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters